Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections

John D. Nelson, Helen Kusmiesz, Sharon Shelton

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In a randomized, prospective clinical trial cefamandole therapy was compared with cefamandole plus amdinocillin in infants and children with suspected bacterial infections. Fifty-two infections in 50 patients with bone and joint (19 infections), pulmonary (19 infections), soft tissue (eight infections), and urinary tract (6 infections) diseases were treated. Bacterial infection was documented in 31 patients. All isolates were susceptible to cefamandole except one strain of Serratia marcescens, which was susceptible to the combination. In vitro synergy was demonstrated in all coliform bacilli, in three of seven Haemophilus strains, and in six of 16 gram-positive cocci. No correlation between degree of serum bactericidal activity and presence or absence of synergy could be demonstrated. One patient treated with cefamandole died; all other patients responded promptly to therapy without serious adverse drug effects.

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalThe American journal of medicine
Volume75
Issue number2 PART 1
DOIs
StatePublished - Aug 29 1983

Fingerprint

Amdinocillin
Cefamandole
Pediatrics
Infection
Bacterial Infections
Haemophilus
Gram-Positive Cocci
Serratia marcescens
Soft Tissue Infections
Enterobacteriaceae
Urinary Tract Infections
Randomized Controlled Trials
Joints
Bone and Bones
Lung
Therapeutics
Serum
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections. / Nelson, John D.; Kusmiesz, Helen; Shelton, Sharon.

In: The American journal of medicine, Vol. 75, No. 2 PART 1, 29.08.1983, p. 125-129.

Research output: Contribution to journalArticle

@article{190e3abfedb248fe9624577804d1dcd3,
title = "Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections",
abstract = "In a randomized, prospective clinical trial cefamandole therapy was compared with cefamandole plus amdinocillin in infants and children with suspected bacterial infections. Fifty-two infections in 50 patients with bone and joint (19 infections), pulmonary (19 infections), soft tissue (eight infections), and urinary tract (6 infections) diseases were treated. Bacterial infection was documented in 31 patients. All isolates were susceptible to cefamandole except one strain of Serratia marcescens, which was susceptible to the combination. In vitro synergy was demonstrated in all coliform bacilli, in three of seven Haemophilus strains, and in six of 16 gram-positive cocci. No correlation between degree of serum bactericidal activity and presence or absence of synergy could be demonstrated. One patient treated with cefamandole died; all other patients responded promptly to therapy without serious adverse drug effects.",
author = "Nelson, {John D.} and Helen Kusmiesz and Sharon Shelton",
year = "1983",
month = "8",
day = "29",
doi = "10.1016/0002-9343(83)90107-9",
language = "English (US)",
volume = "75",
pages = "125--129",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2 PART 1",

}

TY - JOUR

T1 - Randomized trial of cefamandole plus amdinocillin versus cefamandole in serious pediatric infections

AU - Nelson, John D.

AU - Kusmiesz, Helen

AU - Shelton, Sharon

PY - 1983/8/29

Y1 - 1983/8/29

N2 - In a randomized, prospective clinical trial cefamandole therapy was compared with cefamandole plus amdinocillin in infants and children with suspected bacterial infections. Fifty-two infections in 50 patients with bone and joint (19 infections), pulmonary (19 infections), soft tissue (eight infections), and urinary tract (6 infections) diseases were treated. Bacterial infection was documented in 31 patients. All isolates were susceptible to cefamandole except one strain of Serratia marcescens, which was susceptible to the combination. In vitro synergy was demonstrated in all coliform bacilli, in three of seven Haemophilus strains, and in six of 16 gram-positive cocci. No correlation between degree of serum bactericidal activity and presence or absence of synergy could be demonstrated. One patient treated with cefamandole died; all other patients responded promptly to therapy without serious adverse drug effects.

AB - In a randomized, prospective clinical trial cefamandole therapy was compared with cefamandole plus amdinocillin in infants and children with suspected bacterial infections. Fifty-two infections in 50 patients with bone and joint (19 infections), pulmonary (19 infections), soft tissue (eight infections), and urinary tract (6 infections) diseases were treated. Bacterial infection was documented in 31 patients. All isolates were susceptible to cefamandole except one strain of Serratia marcescens, which was susceptible to the combination. In vitro synergy was demonstrated in all coliform bacilli, in three of seven Haemophilus strains, and in six of 16 gram-positive cocci. No correlation between degree of serum bactericidal activity and presence or absence of synergy could be demonstrated. One patient treated with cefamandole died; all other patients responded promptly to therapy without serious adverse drug effects.

UR - http://www.scopus.com/inward/record.url?scp=0020621859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020621859&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(83)90107-9

DO - 10.1016/0002-9343(83)90107-9

M3 - Article

C2 - 6311000

AN - SCOPUS:0020621859

VL - 75

SP - 125

EP - 129

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2 PART 1

ER -